These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 12965318)

  • 1. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
    Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
    Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study.
    Retera JM; Leers MP; Sulzer MA; Theunissen PH
    J Clin Pathol; 1998 Dec; 51(12):891-4. PubMed ID: 10070329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of E-cadherin and alpha-, beta-, and gamma-catenin expression in surgically treated non-small cell lung cancers of 3 cm or less in size.
    Lee YC; Wu CT; Chen CS; Hsu HH; Chang YL
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):502-7. PubMed ID: 11882822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study of E-cadherin and beta-catenin expression and their correlation with prognosis of nonsmall cell lung carcinoma].
    Qiu X; Yang X; Li Q; Wang E
    Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):318-21. PubMed ID: 12417088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
    Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
    J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic value of epithelial growth factor receptor, vascular endothelial growth factor, E-cadherin, and p120 catenin in resected non-small cell lung carcinoma].
    Ucvet A; Kul C; Gursoy S; Erbaycu AE; Kaya SO; Dinc ZA; Yucel N
    Arch Bronconeumol; 2011 Aug; 47(8):397-402. PubMed ID: 21696876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micrometastasis in the bone marrow of patients with lung cancer associated with a reduced expression of E-cadherin and beta-catenin: risk assessment by immunohistochemistry.
    Sugio K; Kase S; Sakada T; Yamazaki K; Yamaguchi M; Ondo K; Yano T
    Surgery; 2002 Jan; 131(1 Suppl):S226-31. PubMed ID: 11821816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of plasma membrane expression/cytoplasmic accumulation of beta-catenin predicts shortened survival in non-small cell lung cancer. A clinicopathologic study of 100 cases.
    Kren L; Hermanová M; Goncharuk VN; Kaur P; Ross JS; Pavlovský Z; Dvorák K
    Cesk Patol; 2003 Jan; 39(1):17-20. PubMed ID: 12673938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.
    Bremnes RM; Veve R; Gabrielson E; Hirsch FR; Baron A; Bemis L; Gemmill RM; Drabkin HA; Franklin WA
    J Clin Oncol; 2002 May; 20(10):2417-28. PubMed ID: 12011119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis].
    Tang XJ; Zhou QH; Zhang SF; Liu LX
    Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
    Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
    Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer.
    Garcia del Muro X; Torregrosa A; Muñoz J; Castellsagué X; Condom E; Vigués F; Arance A; Fabra A; Germà JR
    Eur J Cancer; 2000 Feb; 36(3):357-62. PubMed ID: 10708937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance.
    Kase S; Sugio K; Yamazaki K; Okamoto T; Yano T; Sugimachi K
    Clin Cancer Res; 2000 Dec; 6(12):4789-96. PubMed ID: 11156236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the dysadherin and E-cadherin expression in primary lung cancer and metastatic sites.
    Mitselou A; Batistatou A; Nakanishi Y; Hirohashi S; Vougiouklakis T; Charalabopoulos K
    Histol Histopathol; 2010 Oct; 25(10):1257-67. PubMed ID: 20712010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
    Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
    Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin expression in surgically-resected non-small cell lung cancers--a clinicopathological study.
    Lee YC; Wu CT; Chen CS; Chang YL
    Thorac Cardiovasc Surg; 2000 Oct; 48(5):294-9. PubMed ID: 11100763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma.
    Perez-Ordonez B; Huynh NN; Berean KW; Jordan RC
    J Clin Pathol; 2004 Oct; 57(10):1080-3. PubMed ID: 15452164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors.
    Shimazui T; Schalken JA; Giroldi LA; Jansen CF; Akaza H; Koiso K; Debruyne FM; Bringuier PP
    Cancer Res; 1996 Sep; 56(18):4154-8. PubMed ID: 8797585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of E-cadherin, alpha- and beta-catenins in papillary thyroid carcinoma.
    Kapran Y; Ozbey N; Molvalilar S; Sencer E; Dizdaroğlu F; Ozarmağan S
    J Endocrinol Invest; 2002; 25(7):578-85. PubMed ID: 12150330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of E-cadherin/beta-catenin expression in imprints of NCSLC: relationship with clinicopathological factors.
    Pagaki E; Patsouris E; Gonidi M; Athanassiadou AM; Maurikakis M; Athanassiades P; Chelidonis G; Athanassiadou P
    Diagn Cytopathol; 2010 Jun; 38(6):419-24. PubMed ID: 20474081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.